Seven Innovative Projects Awarded 2026 Koda Kimble Seed Award

Seven Innovative Projects Awarded 2026 Koda Kimble Seed Award

Koda-Kimble
Mary Anne Koda-Kimble, PharmD

Seven innovative projects poised to advance the mission of the UCSF School of Pharmacy in new ways have been selected to receive the 2026 Mary Anne Koda-Kimble Seed Award for Innovation.

Administered by the Center for Collaborative Innovation (CCI) that is led by professor Su Guo, PhD, the annual program this year will fund $65,000 worth of projects for which there is no ready or traditional source of funding. Awards are offered in two categories: individual projects and cross-departmental collaborations.

The award honors the legacy of Mary Anne Koda-Kimble, PharmD, who was the school’s dean from 1998 to 2012 and supported new directions in science, education and patient care. The Seed Award for Innovation was established in 2012 through a $1 million endowment from the Joseph and Vera Long Foundation.

Collaborative Innovation Projects

headshots of Safwaan Khan, Henry Scott and Eunsol Yang in a row
Pictured from left: Safwaan Khan, Henry Scott, and Eunsol Yang
Principal InvestigatorDepartmentProject
Safwaan KhanPharmaceutical ChemistryConversion of TGFβ-Mediated Immunosuppression into CAR-T Cell Activation in Glioblastoma
Henry ScottPharmaceutical ChemistryElectrically Refunctionalizing Cardiac Scar Tissue Using Orthogonal Gap Junctions
Eunsol Yang, PharmD, PhDBioengineering and Therapeutic SciencesCharacterizing patient heterogeneity in longitudinal glycemic outcomes in youth-onset type 2 diabetes to guide optimized treatment

Individual Innovation Projects

four headshots in a row of Emma Gunderson, Conan MacDougall, Daniel Weisberger and Klaus Yserentant
Pictured from left: Emma Gunderson, Conan MacDougall, Daniel Weisgerber, and Klaus Yserentant
Principal InvestigatorDepartmentProject
Emma Gunderson, EdDClinical PharmacyBuilding a Business Model for a Translational Drug Research Institute
Conan MacDougall, PharmD, MASClinical PharmacyLeveraging Large Language Model (LLM)  Capabilities to Facilitate Adoption of Evidence-based Learning Strategies Among Pharmacy Students
Daniel Weisgerber, PhDBioengineering and Therapeutic SciencesMicrofluidic Aggregation of Amyloid Beta for the Study of Alzheimer’s Disease and Drug Testing
Klaus Yserentant, PhDPharmaceutical ChemistryExtended rhodamine binder scaffolds as platform for next generation fluorescent labels